Journal profile · Infectious Diseases
HIV Clinical Trials
ISSN 1528-4336 · eISSN 1945-5771 · Taylor and Francis Ltd. · UNITED STATES · Bimonthly · Founded 2000
HIV Clinical Trials: impact factor 2.1 (journal website); subscription journal; APC charged, amount not published; review about 36 days (first decision after review, publisher); community-reported acceptance: fairly easy.
Scope
Aims, scope and focus
HIV Clinical Trials is published by Taylor and Francis Ltd.. By OpenAlex counts of its recent articles, its largest topics are HIV/AIDS drug development and treatment, HIV-related health complications and treatments and HIV Research and Treatment, together about 62.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
HIV Clinical Trials is devoted exclusively to presenting information on the latest developments in HIV/AIDS clinical research. This journal enables readers to obtain the most up-to-date, innovative research from around the world. " HIV Clinical Trials is a great outlet for our work. The review and editorial process has been fast and fair... could not ask for anything more." - Seth Kalichman, PhD HIV Clinical Trials welcomes authors and researchers to submit their work on: Therapeutic clinical trials, diagnostic clinical trails, or preventive clinical trials; including reports of clinical research, and meta-analysis. Pilot studies on HIV clinical research Methodological papers relating to HIV clinicals Quality of life and pharmacoeconomic evaulations relating to HIV clinicals We also welcome review article submissions and letters to the editor. HIV Clinical Trials uses Editorial Manager for submissions and peer review. Author Benefits The prestigious and experienced members of our international Editorial Board will guide you from submission to publication. If you wish to submit your paper for open access publication we are able to provide you with a variety of options to choose from. Our Author Services page provides you with tips and tricks to promote your research on social media and through your network. This includes 50 free e-prints to share with whomever you choose. We have enabled easy tracking to measure the impact your paper makes with the help of My Authored Works . Sorry, there are currently no metrics available for this journal.
From the journal's Aims & Scope
Research area (LetPub): Infectious Diseases
Editor-in-chief Tristan BarberPublisher website
Editorial board by country: none in mainland China; most named United States 7, United Kingdom 3, Nigeria 2, Germany 1, Spain 1 (15 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- HIV/AIDS drug development and treatmentMedicine24.1%
- HIV-related health complications and treatmentsMedicine19.8%
- HIV Research and TreatmentImmunology and Microbiology18.2%
- HIV/AIDS Research and InterventionsMedicine16.1%
- Hepatitis C virus researchMedicine4.3%
- Biological Research and Disease StudiesBiochemistry, Genetics and Molecular Biology2.7%
- Pneumocystis jirovecii pneumonia detection and treatmentMedicine2.2%
- Hepatitis B Virus StudiesMedicine2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEScopusMEDLINEPubMedEmbaseCurrent ContentsDOAJPublisher website
Other: Elsevier BIOBASE, ISI Alerting Services
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.9Publisher website ·
- CiteScore 2026-06
- 1.76LetPub ·
- CiteScore (publisher) 2025
- 2.2Publisher website ·
- SJR 2026-06
- 0.9LetPub ·
- SJR (publisher) 2025
- 0.58Publisher website ·
- SNIP 2026-06
- 0.47LetPub ·
- SNIP (publisher) 2025
- 0.6Publisher website ·
- h-index
- 48LetPub ·
- h-index
- 62OpenAlex ·
- i10-index
- 470OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Downloads per year (publisher)
- 117,000Publisher website ·
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
36 daysfirst decision after review · community reports over 12 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 43%Publisher website ·
- Submission to first decision
- 28 daysPublisher website ·
- First decision after review
- 36 daysPublisher website ·
- Acceptance to publication
- 8 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAuthorship, Open access
- Authorship
Adopts UNAIDS terminology guidelines; authors must use preferred terminology. Model summary
The journal adopts the UNAIDS terminology guidelines, all authors need to ensure their submission uses the preferred terminology as described in the following: https://www.unaids.org/sites/default/files/media_asset/2015_terminology_guidelines_en.pdf
Source ↗Publisher website ·- Open access Open access
Overview Open journals Open Select Dove Medical Press F1000Research
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- UNITED STATES
- Frequency
- Bimonthly
- Founded
- 2000
- ISSN
- 1528-4336
- Electronic ISSN
- 1945-5771
- Latest issue on the website
- Volume 27, Issue 1 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about HIV Clinical Trials
What is the impact factor of HIV Clinical Trials?
The journal's website gives an impact factor of 2.1 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 1.76, h-index 62.
How long does peer review take at HIV Clinical Trials?
The publisher reports about 36 days (first decision after review); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 43%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of HIV Clinical Trials based?
Of the 15 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (7), United Kingdom (3) and Nigeria (2). Counted from the institutions listed on the board page; for reference only.
Which databases index HIV Clinical Trials?
The journal's website lists SCIE, Scopus, MEDLINE, PubMed, Embase, Current Contents and DOAJ; that list has not been checked against each database.
Is HIV Clinical Trials open access, and what is the APC?
HIV Clinical Trials is a subscription journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .